Max Robotics — Global Service Robot Directory + US Certification

About

Jean de la Rosette is a pioneering urological surgeon whose career has been defined by advancing minimally invasive treatments for urological cancers and benign prostatic disease. His research centers on surgical innovation, training, and outcomes in percutaneous nephrolithotomy (PCNL), ureteroscopy, and robotic-assisted procedures. A landmark 2008 critical review on PCNL training (222 citations) established standards for skill acquisition in complex stone surgery, while his 2018 comparison of retropubic, laparoscopic, and robotic radical prostatectomy (174 citations) provided pivotal evidence guiding surgical choice for prostate cancer. De la Rosette’s 2009 analysis of minimally invasive surgery versus active surveillance for kidney cancer (147 citations) shaped contemporary management paradigms. His systematic review on robotic-assisted simple prostatectomy (2020, 53 citations) further solidified his role in refining treatment for large prostates. Notably, he led a multicenter randomized trial on irreversible electroporation for localized prostate cancer (2023), exploring novel ablation technologies. With over 500 publications and a career spanning three decades, de la Rosette has been a driving force in urological education, surgical quality, and evidence-based practice, earning him international recognition as a thought leader in endourology and robotic surgery.